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Background: Reference intervals are affected by different factors such as lifestyle, ethnicity, age/developmental
stage, gender, nutrition and other environmental factors (Clin Biochem Rev: 29,2008). Therefore, it is obvious that
it should be established for every population in different regions even within a country. Then the aim of this
study is to establish population specific reference intervals of thyroid stimulating hormone, free thyroxine and
free triidothyronine levels of cord blood.
Results: One hundred twenty three cord blood samples collected from the umbilical cord of newborns were analyzed
for thyroid stimulating hormone, free thyroxine and free triidothyronine values. The birth weights ranged between 2500
and 4700 g with mean (SD) value of 3241.46 (459.495) gram. Their gestational age ranged between 37 and 44 weeks
with an average of 39.74 weeks. The 2.5th and 97.5th percentiles of values were found to be 3.48 mIU/L and 27.57 mIU/L
for thyroid stimulating hormone, 0.89 ng/dl and 1.53 ng/dl for free thyroxine and 1.19 pg/ml and 2.51 pg/ml for free
triidothyronine respectively.
Conclusion: In the present study the reference intervals of thyroid stimulating hormone, free thyroxine and free
triidothyronine were established and based on the results obtained, were 3.48–27.56 mIU/L for thyroid stimulating
hormone, 0.89–1.53 ng/dl for free thyroxine and 1.19–2.51 pg/ml for free triidothyronine. It has been concluded that
the result can provide us with an important baseline to establish population specific reference intervals for our country
using large scale studies.
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The development and maturation of the brain and
central nervous system and other target tissues have a
critical dependence on thyroid hormones, beginning
before birth and extending through the first 2–3 years of
life. Therefore, abnormal thyroid function may lead to
different developmental problems. Mental retardation
due to congenital hypothyroidism is one of the serious
consequences of thyroid abnormalities. The incidence of
congenital hypothyroidism ranges from 1 in 3000 to 1 in* Correspondence: amanmehari71@gmail.com
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cause of mental retardation [1]. Thyroid gland secretes
two major hormones, thyroxine and triiodothyronine,
commonly called T4 and T3, respectively [2]. Thyroid
hormone production is regulated by another hormone
called thyroid-stimulating hormone (TSH). TSH is made
by the pituitary gland, which is located in the brain.
From the pituitary gland, TSH travels to the thyroid
where it stimulates the production of T3 and T4 and
their release into the bloodstream [3, 4]. Thyroid func-
tion tests are used to evaluate the thyroid’s functioning
and to diagnose and help determine the cause of thyroid
diseases.le is distributed under the terms of the Creative Commons Attribution 4.0
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factors such as lifestyle, ethnicity, age/developmental
stage, gender, nutrition and other environmental factors
[5], it is obvious that it should be established for every
population in different regions, even within a country.
However, there is no implemented population specific
reference intervals for almost all analysts, including the
thyroid function tests in Ethiopia, let alone for regional
areas. Current pediatric reference intervals for TSH, T4,
and T3 have been derived predominantly from samples
collected on hospitalized infants and children of the
western population [5], and may not reflect levels in
healthy multicultural populations. Application of refer-
ence ranges, specific to other ethnic groups is clinically
inappropriate for many biomarkers including thyroid
function tests. Another problem with the available
pediatric reference intervals, is that they were deter-
mined over two decades ago using older/less accurate
instrumentation and methodologies that are no longer
relevant to testing technology used by clinical laborator-
ies today [6, 7].
Since the 1970’s, neonatal screening programs for
hypothyroidism have been developed and have become
popular worldwide. Specimens from cord blood and fil-
ter paper spotted with blood from a heel break can be
utilized to measure TSH and fT4 for Congenital
hypothyroidism screening. Due to early discharges from
hospitals in Ethiopia, it is usually difficult to take blood
samples from neonates after a few days of life [8]. There-
fore, cord blood is the specimen of choice as it is readily
available at birth, with adequate volume for supplemen-
tal tests when required. Therefore, the cord blood speci-
men is selected in our study with special interest of the
study group to set an indispensable prerequisite of neo-
natal screening program for congenital hypothyroidism
which is part of the postnatal care in the developed
countries. It has been concluded that the result can pro-
vide us with an important baseline to establish popula-
tion specific reference intervals for our country using
large scale studies.
Methods
A cross sectional study was conducted from July, 2013
to January, 2013 using cord blood sample from 123
newborn infants of both sexes. The study involves
consecutive births of newborn infants from Tikur
Anbessa Hospital and Gandhi Memorial Hospital
selected using a set of inclusion and exclusion criteria with
the help of experienced pediatricians and Gynecologist.
Healthy, full term and singleton newborns were in-
cluded and preterm, multiple births and infants with
evidence of infection were excluded from the study. A
convenient sampling technique was used to take 138
study participants. Sample size determination was,according to recommendations of international organi-
zations which states that the preferred method as a
priori nonparametric determination of reference inter-
vals of the single group population should be established
at least from 120 reference individuals. In this study 138
samples were taken with 10 % contingency plan for non
respondents and participants who may excluded after
blood collection. The Clinical Laboratory Standards
Institute (CLSI) and International Federation of Clinical
Chemistry and laboratory medicine (IFCC) were the
main references to decide the sample size of 120. Ac-
cording to those international organizations 120 is the
minimum sample size required to determine reference
intervals for the 95th percentile reference limits (2.5th
and 97.5th percentile).
Five ml Cord blood samples were collected immedi-
ately after birth from the umbilical cord of the neonates
of volunteer parent. Cord blood was obtained after an
uncomplicated vaginal delivery and the umbilical cord
was ligated from the placental side. BD vacutainer EDTA
tubes were used to collect blood sample and the plasma
was separated as soon as possible through centrifugation
at 4600 rpm for 4 min. Plasma samples were stored in a
deep freezer at −20 °C in the department of Biochemis-
try laboratory until it transports to Ethiopian Health and
Nutrition Research Institute (EHNRI). Finally the sam-
ples were transported using the cold box and stored in a
deep freezer at −80 °C in EHNRI Clinical Chemistry
Laboratory until the hormone analysis was done.
Assays of laboratory variables
TSH, fT4 and fT3 were measured using Elecsys 2010
immunoassay analyzer (Cobas®) which is a fully automatic
run-oriented analyzer system for the determination of
immunological tests using the electrochemiluminescence
immunoassay “ECLIA” process. All components and
reagents for routine analysis are integrated in or on the
analyzer. Specific test principles of the hormones to be
measured are explained as follows.
TSH assay
Sandwich immunoassay with total duration of assay of
18 min was used. It has two step incubation periods.
During the first incubation period 50 μL of samples, a
biotinylated monoclonal TSH‑specific antibody and a
monoclonal TSH‑specific antibody labeled with a ruthe-
nium complex react to form a sandwich complex. At the
second incubation streptavidin-coated microparticles
was added and the complex becomes bound to the solid
phase via interaction of biotin and streptavidin. The
reaction mixture was aspirated into the measuring cell
where the microparticles are magnetically captured onto
the surface of the electrode. Unbound substances, then
removed with ProCell/ProCell M. Application of a
Table 1 Birth weight wise distribution of samples
Birth Weight
in gram






Table 2 Distribution of study participants in ranges of
Gestational ages
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sion which was measured by a photomultiplier.
fT3 assay
A competitive immunoassay system with total duration
of assay of 18 min was used. It has two step incubation
periods. During the first incubation period 15 μL of
samples and an anti‑T3‑specific antibody labeled with a
ruthenium complex was mixed. And the second incuba-
tion period starts with the addition of biotinylated T3
and streptavidin-coated microparticles, and the still‑free
binding sites of the labeled antibody become occupied,
with formation of an antibody‑hapten complex. The en-
tire complex binds to the solid phase via interaction of
biotin and streptavidin. The reaction mixture, then aspi-
rated into the measuring cell where the microparticles
are magnetically captured onto the surface of the elec-
trode. Unbound substances were removed with ProCell/
ProCell M. Application of a voltage to the electrode then
induces chemiluminescent emission which was mea-
sured by a photomultiplier.
fT4 assay
A competition immunoassay system with total dur-
ation of assay of 18 min was used. It has two step in-
cubation periods. During the first incubation period
15 μL of samples and an anti‑T4‑specific antibody la-
beled with a ruthenium complex was mixed. And the
second incubation period starts with the addition of
biotinylated T4 and streptavidin-coated microparticles,
and the still-free binding sites of the labeled antibody
become occupied, with formation of an antibody-
hapten complex. The entire complex was bounded to
the solid phase via interaction of biotin and streptavi-
din. The reaction mixture, then aspirated into the
measuring cell where the microparticles are magnetic-
ally captured onto the surface of the electrode.
Unbound substances were removed with ProCell/Pro-
Cell M. Application of a voltage to the electrode then
induces chemiluminescent emission which was mea-
sured by a photomultiplier.
Results of all of the hormones of thyroid functions test
TSH, FT4, FT3 were determined via a calibration curve,
which is instrumental-specifically generated by 2-point
calibration and a master curve provided via the reagent
barcode.
Data management and statistical analysis
Data was analyzed using the SPSS version 20. Prior to
the calculation of reference intervals, data were cleaned.
Records with missing descriptive information and out-
liers were removed before statistical analysis. Outliers
were excluded using the following formulas which are
suggested by most literatures.Outlier excluding formula:
Upper Limit ¼ Q3 þ 2:2  Q3‐Q1ð Þð
Lower Limit ¼ Q1‐ 2:2  Q3‐Q1ð Þð
Where Q stands for Quartile
Once the upper and lower limits are obtained, results
higher than the upper limit and lower than the lower limit
were removed from the data. A net of 123 participants were
included for obtaining the reference intervals. It should be
noted that outliers were not excluded from all data analysis.
The effects of maternal age, gestational age, gender and
birth weight on newborn TSH, FT4 and FT3 levels were
assessed by analysis of variance (ANOVA), multiple correl-
ation coefficient and Spearman’s correlation coefficients.
Multiple linear regressions were performed to quantify the
associations between the above parameters and changes in
TSH, FT4 and FT3 levels. Histogram and Q-Q plot for
visual and Kolmogorov-Smirnove (K-S) Test for numeric
assessment of the distribution of data were used. A prob-
ability level of p < 0.05 was taken as significant.
Since the numerical values of TSH do not have normal
Gaussian distributions, log transformation was required
and the non-parametric method was used which is rec-
ommended by IFCC and CLSI for such type of data with
a minimum of 120 individuals required per partition.
Reference limits were calculated using non-parametric
ascending rank order statistics. The conventional 95th
percentile reference limits were determined by calculat-
ing the rank numbers for the 2.5th and 97.5th percentiles.
Quality control and quality assurance
The quality of the results was maintained by following
the standard operational procedures for analysis of TSH,
fT4 and fT3 prepared by the senior staffs of EHNRI
Fig. 1 Frequency distribution of maternal age of the study participants
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logical controls, Preci control Universal, Roche,
11731416122 PC U1 and PC U2 were also performed
with every run to control the performance of the overall
procedure and the instrument under use. The specified
laboratory is currently participating in international
quality assurance programs which make our result more
reliable.
Results
One hundred twenty three cord blood samples collected
from umbilical cord of newborns with male to female
ratio of 0.83 (56 males and 67 females) were analyzed
for TSH, fT4 and fT3 values. Their birth weight ranged
between 2500 g and 4700 g with mean (SD) value of
3241.46 (459.495) gram and 47 (38.8 %) of them have
birth weight in the range of 3000–3490 g. Table 1 pre-
sents the distribution of study participants in ranges of
birth weight. Their gestational age ranged between 37
and 44 weeks. 74.8 % of them were born in the range of
39–42 weeks of gestational age. Table 2 shows theGestational age
Fig. 2 Frequency distribution of Gestational age of study participantsGestational age distribution of the newborns and Fig. 2
presented it in the histogram. The maternal age is dis-
played in Fig. 1 in which 82.9 % of them were under the
age of 30 years.
The conventional 95th percentile reference limits
(2.5th and 97.5th percentile) method was used to
determine the reference ranges of TSH, fT4 and fT3
values of the cord blood. Prior the establishing of the
reference intervals the data were tested for normal
distribution. The overall distribution of TSH result
was positively skewed (Fig. 3), with skewness and
kurtosis of 1.41 and 1.46 respectively. TSH values
were further tested for normal distribution using
Kolmogorov-Smirnove (K-S = 0.007) test and were not
normally distributed. Based on the K-S test result ob-
tained the lognormalization was necessary. After loga-
rithmically normalized (Fig. 1) and 2.5th and 95.7th
percentile values were computed.
Additionally it founds that there was no correlation of
cord blood values of thyroid function tests with maternal
age, gestational age, birth weight and sex. in weeks
Table 4 Summary of umbilical cord blood TSH levels
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The Minimum and Maximum values after exclusion of
outliers was 2.40 mIU/L and 30.15 mIU/L respectively.
The mean (SD) and median values were 10.27 (6.31) and
8.37 mIU/L respectively. The 2.5th and 97.5th percentiles
of TSH values were found to be 3.48 mIU/L and 27.56
mIU/L respectively (Additional file 1). The combined and
separate mean values for both sexes displayed in Table 3.
Table 4 depicts the TSH values of the entire participants.
fT4 results
The Minimum and Maximum values of fT4 were
0.71 ng/dL and 1.57 ng/dL with mean (SD) and median
values of 1.17 (0.14) and 1.17 ng/dL respectively. 1.16 ng/
dL and 1.19 ng/dL were the mean values for males and
females respectively. The 2.5th and 97.5th percentile were
0.89 ng/dL and 1.53 ng/dL (Table 5) (Additional file 1).
fT3 results
The Minimum and Maximum values of fT3 were
1.08 pg/mL and 3.66 pg/mL with mean (SD) and median
values 1.70 (0.34) and 1.67 pg/mL respectively. The 2.5th
and 97.5th percentiles were 1.19 pg/mL and 2.51 pg/mL
respectively (Additional file 1).
Discussion
Congenital hypothyroidism often causes irreversible
mental retardation if thyroid hormone replacement
therapy is not begun during the first few months of life.
The successful introduction of screening in the 1970’s
has enabled North America, Europe, to a limited extent
Asia, Latin America and a few African countries to
combat the ill effects of Congenital hypothyroidism and
saved lives. Those screening programs have successfully
helped in early diagnosis and treatment of congenital
hypothyroidism [9, 10]. It has not been able to imple-
ment in Ethiopia because of several factors, like cost,
lack of reliable laboratories on a large scale, and unavail-
ability of baseline data to our population. The use of
cord blood TSH or combined with fT4 as a screening
tool is an attractive proposition because of its simplicity
and accessibility. Although several investigators have
measured TSH and T4 in a cord and serum samples
from both premature and term infants, every reference
laboratory needs to establish its own normal values inTable 3 Mean values of cord blood TSH, fT4 and fT3 in male
and female newborns







TSH (mIU/L) 11.17 ± 6.6 9.52 ± 6 10.27 ± 6.31 0.151
fT4 (ng/dL) 1.16 ± 0.14 1.19 ± 0.14 1.17 ± 0.14 0.195
fT3 (pg/mL) 1.67 ± 0.28 1.73 ± 0.34 1.70 ± .034 0.302order to validate its own data and technical expertise.
Population-specific reference intervals are an important
prerequisite for interpreting thyroid hormone measure-
ments. In addition to that, the clinical value of TSH, free
thyroxine and free triiodothyronine analysis depends on
the reference intervals with which they are compared
[5]. Therefore, it is important to have population specific
normal values for this age group to avoid misdiagnosis
and incorrect treatment. The present study was under-
taken to establish standard reference values for better
evaluation of thyroid function in cord sera in selected
hospitals, Addis Ababa, Ethiopia.
Values of TSH analysis is summarized in Table 4 and
it shows a comparable trend with other reports by
various investigators across the globe. 74.0 % of the cord
blood results are less than 12 mIU/L, slightly higher
than reports from India, where 85.75 % of results found
to be less than 12 mIU/L [11, 12]. Comparison of means
of both sexes was performed using one way ANOVA.
Based on the results obtained from this investigation,
there is no statistically significant difference between the
values for males and females in TSH (p value 0.151,),
fT4 (p value 0.195) and fT3 (p value 0.302). This implies
that there is no need to establish gender specific
reference intervals.
Previously, few studies have reported in establishing
cutoff values of cord blood TSH in Ethiopia. One study
from yalemtsehay and co-workers was performed, at the
same study area with the current study, and they
determined the cutoff value of cord blood TSH (the 97.8th
percentile in this case) was 15.4 mIU/L [8]. Another study,Table 5 2.5th and 97.5th percentiles of TSH, fT4 and fT3 values
Variables Prior to log normalized Log normalized
2.5th 97.5th 2.5th 97.5th
TSH (mIU/L) 3.48 27.57 3.48 27.56
fT4 (ng/dL) .89 1.53 0.89 1.53
fT3 (pg/mL) 1.19 2.51 1.19 2.51
TSH results(mIU/L)
Fig. 3 Distribution of TSH results among all the study participants
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TSH values of blood from a heel-pricks in neonates from
six hours of life up to seven days old infants. They
determined the cut- off point for TSH to be 29.4 mIU/l
[13, 14]. In the present work the 97.5th percentile of cord
blood TSH was 27.56mIU/L which shows higher than
reports from yalemtsehay and co-workers. This can be
explained by the difference in method of analysis. Immu-
noradiometric assay was used in the previous study which
had low sensitivity as 16.1 % of males and 30.5 % of
females were reported for undetected results [8]
whereas the lowest values was 2.40 mIU/L in the
present study using the Electrochemiluminescence
Immunoassay Method. Other possible explanations
were the previous study includes all the preterm and
full term infants which can lower the cut-off values
of TSH. Whereas only full term infants were included
in the present work as if it had small sample sizes
relative to the mentioned study.fT3 Res
Fig. 4 Frequency distribution of fT3 resultsMany studies reported that cord blood TSH can be
used as a screening tool for congenital hypothyroidism
from all over the world. A study from Japan had shown
that mixed cord blood is a good sampling technique for
screening of congenital hypothyroidism [15–17]. And it
was concluded that cord TSH had a better specificity
and sensitivity as compared to cord or filter paper T4 at
3–5 days of age. A study from Iran shows the reference
range of TSH concentration ranged from 0.77 to
24.91mlU/mL with a mean value of 7.09 [18, 19] which
had lower values comparing to the present study.
However, the time of establishment shows it was done
with older methods which may have lower sensitivity. This
implies us the importance of method specific and timely
updated reference values. One study from India reported
the 97th percentile result of TSH as 25.8 mIU/L [11] which
was comparable but lower than the result of the present
study. Both of the above studies had lower cut-off values
of TSH relative to the current result obtained which canult in pg/mL
fT4 Result in ng/mL
Fig. 5 Distribution of fT4 result among all study participants
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were used and the difference in the target population.
No study was conducted before with the issue of
establishing reference ranges for the cord blood values
for fT4 and fT3 in Ethiopia. Possibly the result of this
study could be the first population specific base line data.
The 2.5th and 97.5th percentiles are 0.89 ng/dL and
1.53 ng/dL for fT4 and 1.19 pg/mL and 2.51 pg/mL for
fT3 respectively. Figure 5 presents the distribution of fT4
result among all study participants. The data were slightly
skewed with skewness and kutosis value 0.262 and of
0.679 respectively but K-S test result shows fT4 values
were normally distributed. Figure 4 presents the distribu-
tion of fT3 result among all study participants. And the
data was slightly skewed data with skewness and kurtosis
values of 1.973 and 8.24 respectively. K-S test result
indicates fT3 results were normally distributed but have a
close test value with the level of significance (0.053). The
results of test of normally distribution for fT4 and
fT3 shows that result were normally distributed.
Therefore, the reference ranges were calculated dir-
ectly from the untransformed data. The results were
compared with studies from abroad and were com-
parable but slightly lower than results of one study
from Turkey as it reported the 2.5th and 97.5th per-
centiles to be 1.07 ng/dL and 2.02 ng/dL for fT4 and
1.15 pg/mL and 2.81 pg/mL for fT3 [9].
TSH, fT4 and fT3 value were tested using the
nonparametric test, kruska - wallis test, of correlation
with Maternal age, Birth weight and Gestational age.
Despite the reports which concluded that Maternal age
and Gestational age were related to neonatal TSH level
and another study showed that Gestational age was
independently associated with lower cord TSH and high
TT4 [20, 21], there was no statistically significant associ-
ation of the variables with any of the listed maternal and
fetal factors.Conclusion
The study was conducted to estabilish reference intervals of
TSH, FT4 and FT3 in cord blood of newborns. The results
obtained were 3.48 - 27.56 mIU/L for TSH, 0.89 - 1.53 ng/
dL for fT4 and 1.19 - 2.51 pg/mL for fT3. Even though set-
ting of cut-off values need its own expertise panel discus-
sion, based on the reference range of cord TSH obtained in
this study, it is safe to use the conventional cut-off value of
TSH, 20mIU/L, for recall purpose in the target population.
The present study, similar to other reports, suggests that
TSH levels in cord blood might be a feasible alternative
specimen for a congenital hypothyroidism screening
program in countries where neonatal blood is not easily
attainable. In the given situation of Ethiopia, where hos-
pital discharge is within about 24 h [6], using cord blood
samples has to be practiced for screening purpose of
congenital hypothyroidism, given all other necessary infra-
structures put in place. It was confirmed by other studies,
that cord blood could be used to prepare blood spots and
the present study adds cut-off values using improved
method, this shows an excellent progress towards launch-
ing the screening program in our country.
Additional file
Additional file 1: TSH, fT4 and fT3 results of Study participants. (XLSX 15 kb)
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